Application of Chitosan, Chitooligosaccharide, and Their Derivatives in the Treatment of Alzheimer’s Disease
Classic hypotheses of Alzheimer’s disease (AD) include cholinergic neuron death, acetylcholine (ACh) deficiency, metal ion dynamic equilibrium disorder, and deposition of amyloid and tau. Increased evidence suggests neuroinflammation and oxidative stress may cause AD. However, none of these factors...
Main Authors: | Qian-Qian Ouyang, Shannon Zhao, Si-Dong Li, Cai Song |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-11-01
|
Series: | Marine Drugs |
Subjects: | |
Online Access: | https://www.mdpi.com/1660-3397/15/11/322 |
Similar Items
-
Production of Low Molecular Weight Chitosan and Chitooligosaccharides (COS): A Review
by: Cleidiane Gonçalves, et al.
Published: (2021-07-01) -
Enzymatic Modifications of Chitin, Chitosan, and Chitooligosaccharides
by: Michal Benedykt Kaczmarek, et al.
Published: (2019-09-01) -
Selenium-Nanoparticles-Loaded Chitosan/Chitooligosaccharide Microparticles and Their Antioxidant Potential: A Chemical and In Vivo Investigation
by: Kaikai Bai, et al.
Published: (2020-01-01) -
Production of Chitooligosaccharides and Their Potential Applications in Medicine
by: Vincent G. H. Eijsink, et al.
Published: (2010-04-01) -
Inhibition of Bladder Tumor Growth by Chitooligosaccharides in an Experimental Carcinogenesis Model
by: João C. Fernandes, et al.
Published: (2012-11-01)